KORU Medical Systems, Inc.

KRMD Healthcare Medical Instruments & Supplies

KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

3.00 0.03 −0.99%
Market cap
$139.9M
P/E
0.0×
Fwd P/E
−89.3×
Dividend yield
—
F-score
5/9
Altman Z
14.46
Beneish M
−2.90
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(10.52%) (13.70%) (15.58%) (21.71%)

+8 more TTM periods

Piotroski F-Score
5 5 5 5
ROA
(6.81%) (8.17%) (9.52%) (13.62%)
ROIC
(10.50%) (19.76%) (22.51%) (30.91%)
Return on Tangible Assets
(11.19%) (14.18%) (16.22%) (23.46%)
Average Days of Receivables
49.30 53.31 57.95 51.52
Free Cash Flow per Share
0.01 0.00 (0.01) 0.00
Free Cash Flow
0.25 0.12 (0.49) (0.17)
Capital Expenditures
(1.14) (0.59) (0.95) (0.48)
Other line items
Cash ROIC
0.95% 0.47% (1.87%) (0.68%)
Accounts Receivable Turnover
8.07 6.87 6.57 7.27
Accounts Payable Turnover
8.46 7.08 7.93 8.31
Inventory Turnover
4.01 4.25 4.79 3.53
Average Days of Payables
62.73 58.42 53.32 46.42
Days of Inventory on Hand
97.15 99.22 86.48 109.39
Tax Rate
0.02 0.00 2.09 1.40
Research and Development Expense of Revenue
9.90% 10.61% 10.67% 11.15%
Selling, General and Administrative Expense of Revenue
54.44% 55.49% 56.84% 59.29%
Share Based Compensation of Revenue
6.07% 6.24% 6.60% 6.25%
Operating CF/Net income
(0.76) (0.31) (0.18) (0.08)
Depreciation/Fixed assets
0.20 0.18 0.18 0.20
Capex/Depreciation
(1.44) (0.75) (1.17) (0.57)
Revenue per Share
0.98 0.93 0.89 0.85
Operating CF per Share
0.03 0.02 0.01 0.01
Capex per Share
(0.02) (0.01) (0.02) (0.01)
Capex to Sales
0.03 0.01 0.02 0.01

Fold the line items

Columns are period end dates